- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
News 12 results
Cases & Deals
King & Spalding Counsels Global Pharmaceutical Company on Commercialization of Diabetes Treatment
Cases & Deals
Cases & Deals
January 24, 2022
Alden Torch Financial Wins Summary Judgment in Dispute with Developer General Partner
Cases & Deals
August 6, 2021
In Dispute Against Kaiser, California Jury Finds the Reasonable Value of Kaweah Health's Services is 90% of Its Charges
Cases & Deals
May 6, 2020
King & Spalding Joins Los Angeles Coalition to Provide Residents, Businesses COVID-19 Pro Bono Assistance
Cases & Deals
February 13, 2019
King & Spalding Achieves Jury Trial Win For NorthBay Hospitals
Cases & Deals
April 26, 2017
King & Spalding Advises Douglas Emmett in $352.8 Million JV for Acquisition of Two Santa Monica Office Buildings
Cases & Deals
October 27, 2016
IFLR 1000 Counts King & Spalding Among Top Financial & Corporate, Energy & Infrastructure Law Firms Worldwide
Cases & Deals
September 27, 2016
King & Spalding Advises Douglas Emmett in $139.5 Million JV for Acquisition of Santa Monica Office Building
Cases & Deals
July 25, 2016
King & Spalding Advises Douglas Emmett in $225 Million Joint Venture for Acquisition of West L.A. Office Building
Cases & Deals
March 1, 2016
Douglas Emmett, Inc. Taps King & Spalding For $1.34 Billion Acquisition of L.A. Office Buildings and Related Joint Venture
Cases & Deals
August 28, 2015
King & Spalding Obtains Litigation Win on Behalf of Management and Financial Advisory Firm